Open AccessSAT-575 Radiolabeled Somatostatin Receptor Analog 86Y-EB-TATE is Characterized by Superior Tumor Uptake Compared to 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 in Thyroid Cancer Mice Models
Author(s) -
Shilpa Thakur,
Brianna Daley,
Huiyan Lü,
Zhantong Wang,
Orit Jacobson-Weiss,
Dale O. Kiesewetter,
Gang Niu,
Xiaoyuan Chen,
Joanna Kłubo-Gwieździńska
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-575
Subject(s) - somatostatin receptor 2 , somatostatin receptor , dota , agonist , endocrinology , medicine , somatostatin , thyroid , medullary thyroid cancer , radionuclide therapy , cancer research , thyroid cancer , receptor , chemistry , biology , in vivo , microbiology and biotechnology